SONN   $1.26  -59.35% Market Closed

Sonnet BioTherapeutics Holdings, Inc.
Total Cash 3.55M
totalCashPerShare 5.207
EBITDA -12.26M
Total Debt 150.19K
quickRatio 1.31
currentRatio 1.649
Total Revenue 55.88K
debtToEquity 5.736
Revenue/Share 0.019
ROA -0.96928
ROE -2.64567
grossProfits
freeCashflow -9.88M
operatingCashflow -10.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -219.68546
profitMargins 0.0
enterpriseValue -530.15K
forwardPE -0.24933155
floatShares 585.99K
sharesOutstanding 682.66K
sharesShort 20.84K
sharesShortPriorMonth 4.34K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.14%
Short Ratio help_outline 0.68%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 4.014
Price To Book help_outline 0.93
earningsQuarterlyGrowth
netIncomeToCommon -7.99M
trailingEps -0.96%
forwardEps -14.96%
enterpriseToEbitda 0.04
lastDividendValue
lastDividendDate
currentQuarterEstimate -5.04 3Q 2024
institutionsCount 11
lastUpdated Nov. 7, 2024, 3:13 a.m.